Search for: "Pfizer, Inc."
Results 1321 - 1340
of 1,370
Sorted by Relevance
|
Sort by Date
22 Feb 2008, 1:30 pm
Medtronic Inc., No. 06-179, Justice Antonin Scalia said that permitting state juries to impose liability on the maker of an approved device “disrupts the federal scheme,” under which the F.D.A. has the responsibility for evaluating the risks and benefits of a new device and assuring that it is safe and effective for its intended use. [read post]
24 Nov 2024, 9:01 pm
The Securities and Exchange Commission announced on November 22 that it filed 583 total enforcement actions in fiscal year 2024 while obtaining orders for $8.2 billion in financial remedies, the highest amount in SEC history. [read post]
9 May 2007, 1:34 pm
"The Draft continues to use the "carve at the joint" metaphor from In re Rhone-Poulenc Rorer, Inc., 51 F.3d 1293 (7th Cir. 1995) (e.g., §2.03, comment c & Reporters' Notes) to justify widespread issue certification, even though Rhone-Poulenc used that phrase not in support of issue certification, but to caution against bifurcating a trial in a way that would have different juries examining the same issue in violation of the Seventh Amendment. 51 F.3d… [read post]
27 Sep 2007, 11:38 am
Pfizer, Inc., 2004 WL 2191804, *4 & n.4 (S.D. [read post]
2 Aug 2014, 6:05 am
Sinai Hospital and Medical Center of Chicago, Inc., 807 N.E.2d 1026, 1033 (Ill. [read post]
7 Jun 2007, 10:52 am
Pfizer, Inc., 198 F. [read post]
18 Jan 2007, 7:53 pm
Pfizer Inc., No. [read post]
12 Nov 2017, 11:00 pm
A recurring issue in securities cases involves the question of when plaintiffs may rely on the presumption of reliance under the fraud on the market doctrine. [read post]
30 Aug 2016, 2:33 pm
Wyeth, Inc., Dr. [read post]
13 Jun 2013, 7:05 pm
Apple Inc. 12-1158Issue: (1) Whether the offer for sale and/or sale of a product that embodies a patented invention can directly infringe a method claim under 35 U.S.C. [read post]
26 Feb 2024, 6:41 am
The IMR reviewer noted that applicant had a history of auditory hallucinations, which were ameliorated with Geodon, demonstrating the efficacy of that medication and supporting its medical necessity. [ LexisNexis Commentary: This IMR is particularly interesting because the medication Geodon, which was at issue here, was the subject of a $301 million settlement between Pfizer, Inc. and the U.S. [read post]
13 Jan 2023, 3:00 am
National/Federal At Proud Boys Trial, U.S. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the generic… [read post]
23 Feb 2010, 6:16 am
Editor’s Note: John Olson is a founding partner of Gibson, Dunn & Crutcher’s Washington, D.C. office and a visiting professor at the Georgetown Law Center. [read post]
2 Sep 2022, 5:01 am
This new article of mine will be coming out next year in the Journal of Law and Religion, and I thought I'd serialize it here; there's still plenty of time for editing, so I'd love to hear people's feedback. [read post]
10 Jan 2020, 9:32 am
Goodman Distr., Inc., 694 F. [read post]
6 Feb 2013, 9:00 pm
Then later in the summer, the DOJ moved to a 9 point compliance program in the Pfizer DPA. [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
20 Dec 2023, 5:00 am
Monoclonal Antibodies Inc., 1985) protected large genus claims. [read post]
